Eton Pharmaceuticals earnings were -$1.5M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ETON earnings report on Mar 31, 2026 announced Q1 2026 earnings of $1.6M, up 4.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ETON reported annual earnings of -$4.6M, with 20.4% growth.
Eton Pharmaceuticals Earnings Reports & History FAQ
What were Eton Pharmaceuticals's earnings last quarter?
On ETON's earnings call on Invalid Date, Eton Pharmaceuticals (NASDAQ: ETON) reported Q1 2026 earnings per share (EPS) of $0.06, up 200% year over year. Total ETON earnings for the quarter were $1.55 million. In the same quarter last year, Eton Pharmaceuticals's earnings per share (EPS) was -$0.06.
Is Eton Pharmaceuticals profitable or losing money?
As of the last Eton Pharmaceuticals earnings report, Eton Pharmaceuticals is currently losing money. Eton Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$1.48 million, a 67.82% decrease year over year.
What was ETON's earnings growth in the past year?
As of Eton Pharmaceuticals's earnings date in Invalid Date, Eton Pharmaceuticals's earnings has grown year over year. ETON earnings in the past year totalled -$1.48 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.